Targeting GPR110 in HER2-Overexpressing Breast Cancers
Rachel Schiff(Baylor College of Medicine), Meghana V. Trivedi(University of Houston), Raksha R. Bhat(University of Houston), Debashish Sahay(University of Houston)
Unknown
October 1, 2015
Cited by 0
Related Papers
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
|Endocrine Reviews|2008|545
Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
|Cancer Research|2008|494
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485